Annual Drug Patent Expirations for AXIRON
Axiron is a drug marketed by Eli Lilly And Co and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AXIRON.
This drug has fifty-five patent family members in fifteen countries.
The generic ingredient in AXIRON is testosterone. Additional details are available on the testosterone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com